Getting to Grip with Non-Invasive Tests to Assess Liver Fibrosis & Patient Eligibility for Novel MASH Therapies

Nov 10 2025
Convention Center: Room 150, Level 1
12:30 PM - 2:00 PM

Description

Join us for a symposium on liver fibrosis designed to encourage the exchange of ideas between leaders in the field and attendees.


Supported by: Siemens Healthineers

Organized by: Medscape Education


For more information and to register, visit: https://events.medscape… />
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

Journey Maps

Objectives

  • Have increased knowledge regarding the: Cut-off values for use of noninvasive tests to assess liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH). Clinical data on novel therapies for MASH.
  • Have greater competence related to evaluating liver fibrosis in patients with MASH
  • Demonstrate greater confidence in their ability to assess for liver fibrosis using noninvasive tests